Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 2
1947 2
1948 1
1956 1
1957 1
1960 2
1963 1
1971 1
1974 1
1976 7
1977 3
1979 2
1981 1
1982 2
1983 6
1984 2
1985 3
1986 2
1987 1
1989 2
1990 2
1991 1
1992 1
1995 1
1996 1
1997 1
1998 2
2003 1
2008 2
2010 3
2011 3
2012 2
2013 6
2014 7
2015 4
2016 1
2017 5
2018 5
2019 7
2020 14
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year
Filters applied: . Clear all
Page 1
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis PA, Özgüroğlu M; PACIFIC Investigators. Antonia SJ, et al. Among authors: wadsworth c. N Engl J Med. 2017 Nov 16;377(20):1919-1929. doi: 10.1056/NEJMoa1709937. Epub 2017 Sep 8. N Engl J Med. 2017. PMID: 28885881 Free article. Clinical Trial.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Özgüroğlu M; PACIFIC Investigators. Antonia SJ, et al. Among authors: wadsworth c. N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280658 Clinical Trial.
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFIC.
Gray JE, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, Cho BC, Planchard D, Paz-Ares L, Faivre-Finn C, Vansteenkiste JF, Spigel DR, Wadsworth C, Taboada M, Dennis PA, Özgüroğlu M, Antonia SJ. Gray JE, et al. Among authors: wadsworth c. J Thorac Oncol. 2020 Feb;15(2):288-293. doi: 10.1016/j.jtho.2019.10.002. Epub 2019 Oct 14. J Thorac Oncol. 2020. PMID: 31622733 Free PMC article. Clinical Trial.
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial.
Paz-Ares L, Spira A, Raben D, Planchard D, Cho BC, Özgüroğlu M, Daniel D, Villegas A, Vicente D, Hui R, Murakami S, Spigel D, Senan S, Langer CJ, Perez BA, Boothman AM, Broadhurst H, Wadsworth C, Dennis PA, Antonia SJ, Faivre-Finn C. Paz-Ares L, et al. Among authors: wadsworth c. Ann Oncol. 2020 Jun;31(6):798-806. doi: 10.1016/j.annonc.2020.03.287. Epub 2020 Mar 21. Ann Oncol. 2020. PMID: 32209338 Free PMC article.
Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC).
Faivre-Finn C, Spigel DR, Senan S, Langer C, Perez BA, Özgüroğlu M, Daniel D, Villegas A, Vicente D, Hui R, Murakami S, Paz-Ares L, Broadhurst H, Wadsworth C, Dennis PA, Antonia SJ. Faivre-Finn C, et al. Among authors: wadsworth c. Lung Cancer. 2021 Jan;151:30-38. doi: 10.1016/j.lungcan.2020.11.024. Epub 2020 Nov 26. Lung Cancer. 2021. PMID: 33285469 Free article. Clinical Trial.
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
Garassino MC, Cho BC, Kim JH, Mazières J, Vansteenkiste J, Lena H, Corral Jaime J, Gray JE, Powderly J, Chouaid C, Bidoli P, Wheatley-Price P, Park K, Soo RA, Huang Y, Wadsworth C, Dennis PA, Rizvi NA; ATLANTIC Investigators. Garassino MC, et al. Among authors: wadsworth c. Lancet Oncol. 2018 Apr;19(4):521-536. doi: 10.1016/S1470-2045(18)30144-X. Epub 2018 Mar 12. Lancet Oncol. 2018. PMID: 29545095 Free PMC article. Clinical Trial.
Mucosal immunity.
Hanson LA, Ahlstedt S, Andersson B, Carlsson B, Cole MF, Cruz JR, Dahlgren U, Ericsson TH, Jalil F, Khan SR, Mellander L, Schneerson R, Edén CS, Söderström T, Wadsworth C. Hanson LA, et al. Among authors: wadsworth c. Ann N Y Acad Sci. 1983 Jun 30;409:1-21. doi: 10.1111/j.1749-6632.1983.tb26855.x. Ann N Y Acad Sci. 1983. PMID: 6191608 Review.
Mapping of population disparities in the cholangiocarcinoma urinary metabolome.
Alsaleh M, Leftley Z, O'Connor T, Hughes T, Barbera TA, Koomson LK, Zabron A, Reeves H, Cramp M, Ryder SD, Greer S, Prince M, Sithithaworn P, Khuntikeo N, Loilome W, Yongvanit P, Cox IJ, Williams R, Wadsworth CA, Holmes E, Nash K, Andrews R, Taylor-Robinson SD. Alsaleh M, et al. Among authors: wadsworth ca. Sci Rep. 2021 Oct 28;11(1):21286. doi: 10.1038/s41598-021-00530-0. Sci Rep. 2021. PMID: 34711878 Free PMC article.
Frozen shoulder.
Wadsworth CT. Wadsworth CT. Phys Ther. 1986 Dec;66(12):1878-83. doi: 10.1093/ptj/66.12.1878. Phys Ther. 1986. PMID: 3786418
106 results